Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

A Quick Comparison: CJC-1295 With vs. Without DAC

To help researchers make informed decisions for their studies, we've put together a simple table outlining the key differences between the two primary forms of CJC-1295. This is the kind of practical knowledge our team believes is essential for designing effec

This comparison does not assign a generated winner or score.

  • To help researchers make informed decisions for their studies, we've put together a simple table outlining the key differences between the two primary forms of CJC-1295. This is the kind of practical knowledge our team believes is essential for designing effective experiments.
  • Synonyms
  • CJC-1295 DAC
  • Mod GRF 1-29, CJC-1295 no DAC
  • Half-Life
  • ~8 days
  • ~30 minutes
  • GH Release Pattern
  • Sustained, continuous elevation (a 'bleed')
  • Pulsatile, mimicking natural body rhythms
  • Typical Research Dosing Frequency
  • Infrequent (e.g., once or twice a week)
  • Frequent (e.g., multiple times per day)
  • Commonly Studied With
  • Often studied alone due to its long action
  • Frequently studied with a GHRP like Ipamorelin or GHRP-6
  • Primary Research Use Case
  • Studies requiring long-term, stable elevation of GH levels
  • Studies aiming to replicate or analyze natural, pulsatile GH secretion
  • Legal Status for Research
  • Same as non-DAC version: For research use only
  • Same as DAC version: For research use only
  • This table makes it clear: the choice between them is entirely dependent on the research question. There isn't a 'better' version, only a 'more appropriate' version for a specific experimental design. The vast majority of modern research protocols we see favor the precision and control of the pulsatile release from CJC 1295 NO DAC.
More references

Related material